🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Long-term Assessment of Patients Treated in the ICU for Sepsis

Recruitingn/aAges 18 Years - anyAllHospital Israelita Albert Einstein
NCT07502794 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is a prospective, observational cohort clinical registry designed to describe clinical and epidemiological characteristics and outcomes of adult patients hospitalized with sepsis. Participants will be followed during hospitalization and after hospital discharge to evaluate short- and long-term outcomes.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Clinical diagnosis of sepsis or septic shock during ICU hospitalization, according to the Sepsis-3 definition. * Age ≥18 years. * Written informed consent obtained from the participant or a legally authorized representative. Exclusion Criteria: * Limited prognosis with a life expectancy of less than 3 months due to conditions not related to sepsis. * Refusal to participate in the study
💊

What it tests

  • Usual Care
📍

Where

1 site
Hospital São Vicente de Paulo
Passo Fundo, Brazil
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy